KEEP BUT DO NOT DISPLAY

  FDA Advisory Committee Recommends Approval of First in Class SGLT-2(Canagliflozin). Next Once Weekly GLP-1 (albiglutide) Submitted to FDA for Approval. Looking for 10,000 seniors to participate in a free program to prevent diabetes (See Item #2).

A meta-analysis found high-dose statin treatment may increase the risk of new onset diabetes in people with two or more risk factors for diabetes. However, those who were at low risk of diabetes did not show an increased risk of diabetes despite receiving high statin doses, researchers said. Journal of …

Middle-aged and older adults who were diagnosed with type 2 diabetes through office screening had a worse baseline risk profile than those whose type 2 diabetes was diagnosed based on clinical signs and symptoms, a study indicated. Researchers found that the risks of stroke, heart attack or cardiovascular death at …

In a small sample of healthy participants who were not currently participating in an exercise program, a low-intensity exercise combination of walking and light resistance exercises suppressed the elevation of post-meal triglyceride concentration after eating a high-fat meal. This effect was noted in VLDL, LDL, and HDL fractions. Findings indicate …

First SGLT-2 First-in-Class Drug to Treat Diabetes Under Scrutiny See this week’s Item #3.

U.S. researchers looked at 1,218 6- to 11-year-olds included in the 2009-2010 National Health and Nutrition Examination Survey and found that only 38.3% met both daily physical-activity and screen-time recommendations. More than 70% of respondents got the recommended one hour or more of moderate-to-vigorous physical activity daily, while 53.5% had …

Americans have shorter average life expectancy than people in other wealthy nations and are more likely to engage in unhealthy behaviors such as consuming high-fat, high-calorie diets, according to a report. The U.S. fared poorly on metrics such as obesity and diabetes, infant mortality and teen pregnancy when compared with …

Many frustrated physicians are likely to abandon Medicare this year over its unpredictable funding despite the decision to delay for one year a cut in Medicare payments for doctors, according to medical associations and physicians. "The Medicare program has become unreliable and its instability undermines efforts by physicians to implement …

Novo Nordisk announced that the Japanese Ministry of Health has approved Ryzodeg® (insulin degludec/insulin aspart) for the treatment of diabetes. Ryzodeg is a soluble formulation of Tresiba (insulin degludec), a once-daily new generation basal insulin analogue with an ultra-long duration of action, and NovoRapid® (insulin aspart which in the US …

Prediabetic and diabetic men may have increased risk of sudden cardiac death. Results from recent research showed that men with pre-diabetes or type 2 diabetes had a higher risk of sudden cardiac death (death from heart-related causes soon after symptoms start), compared to men with normal blood sugar levels. As …